Earnings Labs
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$9.70

-3.77%

Mkt Cap $119.71M

EPS — Estimate vs Actual

Revenue — Estimate vs Actual

Quarterly History

Q1 2026

Mar 9, 2026

$1.67M-$1.78-$1.25+29.78%
Q4 2025

Nov 12, 2025

$1.11M-$1.80-$1.90-5.56%
Q3 2025

Aug 5, 2025

-$1.55-$1.44+7.10%
Q2 2025

May 6, 2025

-$1.26-$1.39-10.32%
Q1 2025

Mar 11, 2025

-$1.02-$0.78+23.53%
Q4 2024

Nov 7, 2024

-$0.99-$1.15-16.16%
Q3 2024

Aug 6, 2024

-$1.16-$0.90+22.41%
Q2 2024

May 7, 2024

-$1.09-$0.83+23.85%
Q1 2024

Mar 12, 2024

$1.35M-$2.36-$1.81+23.31%
Q4 2023

Nov 7, 2023

-$2.06-$2.27-10.19%
Q3 2023

Aug 8, 2023

-$3.10-$2.05+33.87%
Q2 2023

May 9, 2023

-$4.09-$4.24-3.67%
Q1 2023

Mar 7, 2023

-$2.10-$2.61-24.29%
Q4 2022

Nov 8, 2022

-$1.80-$2.10-16.67%
Q3 2022

Aug 9, 2022

$200.00K-$1.80-$2.10-16.67%
Q2 2022

May 10, 2022

$150.00K-$2.70-$2.40+11.11%
Q1 2022

Mar 8, 2022

$347.50K-$881.71K-353.73%-$3.30-$2.40+27.27%
Q4 2021

Nov 12, 2021

$610.00K$97.32K-84.05%-$3.60-$0.60+83.33%
Q3 2021

Aug 12, 2021

$137.00K$136.56K-0.32%-$3.60-$4.50-25.00%
Q2 2021

May 13, 2021

$691.01K$647.82K-6.25%-$4.50-$4.20+6.67%
Q1 2021

Mar 15, 2021

$658.20K-$6.61-$3.00+54.61%
Q4 2020

Nov 10, 2020

$1.23M-$12.31-$12.91-4.87%
Q3 2020

Aug 6, 2020

$214.76K$286.35K+33.33%-$11.41-$15.62-36.90%
Q2 2020

May 11, 2020

$1.64M$1.76M+7.50%-$12.91-$12.91+0.00%
Q1 2020

Mar 12, 2020

$2.26M$2.57M+13.89%-$10.21-$12.31-20.57%
Q4 2019

Nov 7, 2019

$3.08M$2.59M-15.79%-$10.81-$9.61+11.10%
Q3 2019

Aug 8, 2019

$349.13M$29.09M-91.67%-$10.68$0.90+108.43%
Q2 2019

May 9, 2019

$1.18M$1.89M+59.26%$0.60-$12.91-2251.67%
Q1 2019

Mar 12, 2019

$1.67M$1.93M+15.38%-$6.61-$9.01-36.31%
Q4 2018

Nov 8, 2018

$923.05K$1.09M+18.18%-$6.31-$7.81-23.77%
Q3 2018

Aug 8, 2018

$853.65K$853.65K+0.00%-$6.01-$6.31-4.99%
Q2 2018

May 10, 2018

$633.63K$950.44K+50.00%-$2.40-$6.31-162.92%
Q1 2018

Mar 12, 2018

$1.74B-$2.44M-100.14%-$4.80-$6.01-25.21%
Q4 2017

Nov 8, 2017

$910.07K$796.31K-12.50%-$5.11-$4.20+17.81%
Q3 2017

Aug 9, 2017

$443.57K$350.19K-21.05%-$5.71-$4.50+21.19%
Q2 2017

May 9, 2017

$1.29M$1.29M+0.00%-$5.11-$4.80+6.07%
Q1 2017

Mar 9, 2017

$250.45K$375.67K+50.00%-$3.30-$5.41-63.94%
Q4 2016

Nov 10, 2016

$618.80K$742.56K+20.00%-$2.40-$3.60-50.00%
Q3 2016

Aug 15, 2016

$252.38K$396.60K+57.14%-$1.50-$3.30-120.00%
Q2 2016

May 16, 2016

$396.60K$396.60K+0.00%-$2.40-$2.40+0.00%
Q1 2016

Mar 29, 2016

$364.29K$364.29K+0.00%-$1.80-$1.80+0.00%
Q4 2015

Nov 10, 2015

$227.27K$170.45K-25.00%-$2.40-$1.80+25.00%
Q3 2015

Aug 13, 2015

$113.64K-$1.80-$3.00-66.67%
Q2 2015

May 13, 2015

-$1.50-$1.80-20.00%
Q1 2015

Feb 10, 2015

-$1.46
Q4 2014

Nov 14, 2014

-$0.77
Q4 2014

Oct 28, 2014

-$0.59
Q1 2014

Mar 31, 2014

-$0.13
Q4 2013

Dec 31, 2013

-$0.34
Q3 2013

Sep 30, 2013

-$0.07
Q2 2013

Jun 30, 2013

-$0.49
Q1 2013

Mar 31, 2013

-$0.29